Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $23.80 USD
Change Today +0.89 / 3.88%
Volume 594.9K
FMI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

foundation medicine inc (FMI) Snapshot

Open
$23.25
Previous Close
$22.91
Day High
$24.33
Day Low
$23.04
52 Week High
01/12/15 - $54.28
52 Week Low
10/1/14 - $18.25
Market Cap
818.3M
Average Volume 10 Days
414.6K
EPS TTM
$-2.07
Shares Outstanding
34.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FOUNDATION MEDICINE INC (FMI)

foundation medicine inc (FMI) Related Businessweek News

View More BusinessWeek News

foundation medicine inc (FMI) Details

Foundation Medicine, Inc. provides various molecular information products in the United States. Its molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care; and offers genomic information about each patient’s individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted oncology therapies. The company provides clinical products, such as FoundationOne for solid tumors; and FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and myeloma, as well as sarcomas and pediatric cancers. It also offers FoundationCORE, a knowledgebase to publish scientific and medical advances, foster relationships throughout the oncology community, and develop new clinical and technology products. In addition, the company has a strategic collaboration agreement with WuXi PharmaTech Inc. to provide genomic profiles to biopharmaceutical companies conducting clinical trials; and F. Hoffmann-La Roche Ltd. to develop and commercialize molecular information and genomic analysis products for the treatment of cancer patients. The company was founded in 2009 and is headquartered in Cambridge, Massachusetts.

293 Employees
Last Reported Date: 03/13/15
Founded in 2009

foundation medicine inc (FMI) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $416.0K
President and Chief Operating Officer
Total Annual Compensation: $357.8K
Chief Medical Officer
Total Annual Compensation: $357.9K
Chief Commercial Officer
Total Annual Compensation: $50.6K
Compensation as of Fiscal Year 2014.

foundation medicine inc (FMI) Key Developments

Foundation Medicine, Inc. Presents at UBS Genomics 2.0 Summit, Aug-13-2015 08:30 AM

Foundation Medicine, Inc. Presents at UBS Genomics 2.0 Summit, Aug-13-2015 08:30 AM. Venue: The St. Regis Deer Valley, Park City, Utah, United States. Speakers: Alexis Borisy, Co-Founder, Chairman, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee.

Foundation Medicine, Inc. Reports Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for 2015

Foundation Medicine, Inc. reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2015. The company reported total revenue of $22,458,000 compared to $14,496,000 a year ago. Loss from operations was $33,059,000 against $13,763,000 for the same period of last year. Net loss applicable to common stockholders was $33,050,000 against $13,779,000 for the same period of last year. Net loss per basic and diluted share applicable to common stockholders was $0.98 against $0.49 for the same period of last year. For the six months, revenue was $41,753,000 against $25,951,000 for the same period of last year. Loss from operations was $50,031,000 against $25,904,000 for the same period of last year. Net loss applicable to common stockholders was $50,015,000 against $25,945,000 for the same period of last year. Net loss per basic and diluted share applicable to common stockholders was $1.60 against $0.93 for the same period of last year. For the year 2015. The company expects revenue will be in the range of $85 to $95 million.

Foundation Medicine, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 03:05 PM

Foundation Medicine, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 03:05 PM. Venue: Le Parker Meridian, 119 West 56th Street, New York, NY 10019, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMI:US $23.80 USD +0.89

FMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Fluidigm Corp $11.70 USD +0.32
Luminex Corp $18.46 USD -0.07
NanoString Technologies Inc $15.26 USD +0.82
NeoGenomics Inc $6.28 USD +0.30
Veracyte Inc $8.74 USD +0.47
View Industry Companies
 

Industry Analysis

FMI

Industry Average

Valuation FMI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.5x
Price/Book 2.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit www.foundationmedicine.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.